Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

NVS vs LITE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NVS Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

NVS Overall Winner 6-Pillar Tally: NVS 4 – 2 LITE Matrix Metrics: NVS 7 – 3 LITE

As of Nov 16, 2026, Novartis AG (NVS) is the stronger overall head-to-head candidate over Lumentum Holdings Inc. (LITE) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NVS carries a Unified Composite Score of 41.5/100 (SELL) at $161.59 (16.2x Forward P/E, 34.0% operating margin), whereas LITE carries 58.0/100 (HOLD) at $546.65 (17.9x Forward P/E, 23.4% operating margin).

  • Composite vs. Pillar Nuance: While LITE currently prints a higher short-term Unified Composite Score (58.0/100 HOLD vs. NVS 41.5/100 SELL), NVS captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (34.0% vs. 23.4% operating margin) and revenue trajectory (+4.7% vs. +136.5% YoY).
  • Technical & Structure Timing Caution: NVS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 60.8); meanwhile LITE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NVS vs LITE
NVS NYSE Head-to-Head Winner
Novartis AG
Pharmaceutical Preparations
$161.59
+0.68% 1D
Market Cap $302.9B
TTM Revenue $40.5B
Forward P/E 16.2x
Beta / 30D Vol 0.31β · 27% Vol
Unified Composite Score
41.5 / 100 SELL
Tech 29.0 Fund 38.0 Flow 50.0 Mom 21.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (0.7% over 20 days), RSI 61
RSI-14: 60.8 · SMA20: $159.19 · SMA50: $149.17
LITE NASDAQ
Lumentum Holdings Inc. Common Stock
Communications Equipment, Nec
$546.65
-8.38% 1D
Market Cap $53.6B
TTM Revenue $3.74B
Forward P/E 17.9x
Beta / 30D Vol 3.16β · 133% Vol
Unified Composite Score
58.0 / 100 HOLD
Tech 63.0 Fund 57.0 Flow 59.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 35
RSI-14: 34.9 · SMA20: $709.10 · SMA50: $860.63

6-Pillar Scorecard Institutional Category Breakdown (NVS 4 – 2 LITE)

Columns: Metric · NVS · LITE
1. Valuation Multiples NVS
Forward P/E 16.2x 17.9x
Trailing P/E 30.6x 29.3x
PEG Ratio 3.81x 0.63x
EV / Revenue 7.5x 14.4x
2. Growth & Scale NVS
Revenue Growth (YoY) +4.7% +136.5%
Earnings Growth (YoY) -68.8% N/A
TTM Revenue (USD) $40.5B $3.74B
Market Cap $302.9B $53.6B
3. Profitability & Quality NVS
Gross Margin 75.2% 48.0%
Operating Margin 34.0% 23.4%
Net Profit Margin 17.5% -175.8%
Return on Equity (ROE) 24.3% -245.8%
4. Balance Sheet & Cash Flow NVS
Cash Generation (TTM) $17.0B EBITDA $356M
Cash Flow Margin 42.0% EBITDA Mgn 9.5%
Net Cash / Leverage $19.71 Book/Sh · 24.3% ROE $158M Net Debt (0.31x D/E)
Dividend Yield 2.96% None (0.00%)
5. Options & Positioning LITE
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile 16.9% (6th %ile) 76.7% (13th %ile)
Put/Call OI Skew Thin ADR Chain 1.23x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat LITE
OpEx & R&D Intensity 41.2% of Rev ($16.7B) 24.6% of Rev ($921M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Concentrated Oligopoly Moat
Supply-Chain Role Drug Manufacturers - General Operator Communication Equipment Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NVS (7) vs LITE (3)
Institutional Metric NVS LITE Criterion Row Edge
Market Capitalization
Scale
$302.9B $53.6B Larger Scale NVS
Trailing P/E Ratio
Valuation
30.6x 29.3x Lower Multiple LITE
Forward P/E Ratio
Valuation
16.2x 17.9x Lower Multiple NVS
Revenue Growth (YoY)
Growth
+4.7% +136.5% Higher Growth LITE
Operating Margin (TTM)
Profitability
34.0% 23.4% Higher Margin NVS
Net Profit Margin
Profitability
17.5% -175.8% Higher Margin NVS
Return on Equity (ROE)
Capital Efficiency
24.3% -245.8% Higher ROE NVS
52-Week Range Position
Momentum
81% ($123–$170) 36% ($215–$1,143) Stronger Trend NVS
Beta / 30D Volatility
Risk Regime
0.31β · 27% Vol 3.16β · 133% Vol Lower Realized Risk NVS
Unified Institutional Score
Composite Signal
41.5 / 100 (SELL) 58.0 / 100 (HOLD) Higher Composite LITE
Trailing 12M Revenue (USD)
Operating Scale
$40.5B $3.74B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
75.2% 48.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.81x PEG · 7.5x EV/Rev 0.63x PEG · 14.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$17.0B EBITDA ($19.71 Book/Sh · 24.3% ROE) $356M ($158M Net Debt (0.31x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NVS +40.95 pp
NVS: +7.28% · LITE: -33.67%
3M Horizon NVS +41.96 pp
NVS: +4.56% · LITE: -37.4%
6M Horizon NVS +46.57 pp
NVS: +8.34% · LITE: -38.23%
1Y Horizon LITE +118.46 pp
NVS: +22.5% · LITE: +140.96%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NVS vs LITE. Trailing 12-month operating profitability (NVS 34.0% vs LITE 23.4%) and valuation multiples (NVS 16.2x vs LITE 17.9x Forward P/E) are benchmarked directly in Pillar 4 below.

NVS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$40.5B
Gross Margin75.2%
Op. Margin34.0%
ROE / Fwd P/E24.3% · 16.2x
LITE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.74B
Gross Margin48.0%
Op. Margin23.4%
ROE / Fwd P/E-245.8% · 17.9x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NVS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 16.9%
IV Percentile 6th %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NVS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LITE BREAKDOWN
130d in phase · OBV NEUTRAL
Current IV 76.7%
IV Percentile 13th %ile
Put/Call OI Skew 1.23x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact LITE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NVS Moat Profile High-Margin Pricing Power Moat
Drug Manufacturers - General Operator
Competes within the Drug Manufacturers - General value chain with $302.9B market capitalization and 34.0% operating margin.
OpEx & R&D Reinvestment 41.2% of Rev ($16.7B)
90D Engineering Disclosures 0 Published
LITE Moat Profile Concentrated Oligopoly Moat
Communication Equipment Operator
Competes within the Communication Equipment value chain with $53.6B market capitalization and 23.4% operating margin.
OpEx & R&D Reinvestment 24.6% of Rev ($921M)
90D Engineering Disclosures 0 Published · Silicon Photonics
Mapped Supply-Chain Ecosystem (18 partners):
Corning Coherent Sumitomo Electric Industries Furukawa Electric

Investor FAQ NVS vs LITE Key Questions & Quantitative Answers

As of Nov 16, 2026, Novartis AG (NVS) is the stronger overall head-to-head candidate over Lumentum Holdings Inc. (LITE) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NVS carries a Unified Composite Score of 41.5/100 (SELL) at $161.59 (16.2x Forward P/E, 34.0% operating margin), whereas LITE carries 58.0/100 (HOLD) at $546.65 (17.9x Forward P/E, 23.4% operating margin). Composite vs. Pillar Nuance: While LITE currently prints a higher short-term Unified Composite Score (58.0/100 HOLD vs. NVS 41.5/100 SELL), NVS captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (34.0% vs. 23.4% operating margin) and revenue trajectory (+4.7% vs. +136.5% YoY). Technical & Structure Timing Caution: NVS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 60.8); meanwhile LITE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NVS leads the Growth & Scale pillar: NVS posts +4.7% YoY revenue growth and -68.8% YoY earnings growth on $40.5B TTM revenue (75.2% gross margin, 34.0% operating margin), compared with LITE at +136.5% YoY revenue growth and N/A YoY earnings growth on $3.74B TTM revenue (48.0% gross margin, 23.4% operating margin). On trailing 12-month operating scale, NVS generates $40.5B in USD-normalized revenue versus $3.74B for LITE. In operating R&D and SG&A reinvestment, NVS deploys 41.2% of Rev ($16.7B) (0 90-day corporate R&D disclosures) versus 24.6% of Rev ($921M) (0 disclosures) for LITE.

NVS screens cheaper on headline valuation multiples. NVS trades at 16.2x Forward P/E, 30.6x Trailing P/E, 3.81x PEG, and 7.5x EV/Revenue (42.0% EBITDA margin), whereas LITE trades at 17.9x Forward P/E, 29.3x Trailing P/E, 0.63x PEG, and 14.4x EV/Revenue (9.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NVS (24.3% ROE) versus LITE (-245.8% ROE) capital efficiency.

In options market volatility and institutional positioning, NVS carries 16.9% implied volatility (6th %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.31β · 27% Vol realized risk). By comparison, LITE carries 76.7% implied volatility (13th %ile, Compressed (<25th %ile)), a 1.23x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.16β · 133% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.